//
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T
Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
Unexpectedly Low Natriuretic Peptide Levels in Patients With Heart Failure
Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial
Glucose-lowering Drugs or Strategies, Atherosclerotic Cardiovascular Events, and Heart Failure in People With or at Risk of Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis of Randomised Cardiovascular Outcome Trials
Nitrosative stress drives heart failure with preserved ejection fraction
Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification